These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27482962)

  • 1. Diabetes Mellitus in Living Pancreas Donors: Use of Integrated National Registry and Pharmacy Claims Data to Characterize Donation-Related Health Outcomes.
    Lam NN; Schnitzler MA; Segev DL; Hess GP; Kasiske BL; Randall HB; Axelrod D; Xiao H; Garg AX; Brennan DC; Lentine KL
    Transplantation; 2017 Jun; 101(6):1276-1281. PubMed ID: 27482962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records.
    Lentine KL; Koraishy FM; Sarabu N; Naik AS; Lam NN; Garg AX; Axelrod D; Zhang Z; Hess GP; Kasiske BL; Segev DL; Henderson ML; Massie AB; Holscher CM; Schnitzler MA
    Clin Transplant; 2019 Oct; 33(10):e13696. PubMed ID: 31421057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Outcomes for Living Pancreas Donors in the Modern Era.
    Kirchner VA; Finger EB; Bellin MD; Dunn TB; Gruessner RW; Hering BJ; Humar A; Kukla AK; Matas AJ; Pruett TL; Sutherland DE; Kandaswamy R
    Transplantation; 2016 Jun; 100(6):1322-8. PubMed ID: 27203593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Postdonation Outcomes in US Living Kidney Donors Using Publicly Available Data Sets.
    Chen J; Bhattacharya S; Sirota M; Laiudompitak S; Schaefer H; Thomson E; Wiser J; Sarwal MM; Butte AJ
    JAMA Netw Open; 2019 Apr; 2(4):e191851. PubMed ID: 30977847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation.
    Lentine KL; Lam NN; Schnitzler MA; Hess GP; Kasiske BL; Xiao H; Axelrod D; Garg AX; Schold JD; Randall H; Dzebisashvili N; Brennan DC; Segev DL
    Am J Transplant; 2017 Mar; 17(3):744-753. PubMed ID: 27589826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous pancreas kidney transplant versus other kidney transplant options in patients with type 2 diabetes.
    Wiseman AC; Gralla J
    Clin J Am Soc Nephrol; 2012 Apr; 7(4):656-64. PubMed ID: 22344508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Hypertension and Diabetes After Living Kidney Donation: A National Cohort Study.
    Holscher CM; Bae S; Thomas AG; Henderson ML; Haugen CE; DiBrito SR; Muzaale AD; Garonzik Wang JM; Massie AB; Lentine KL; Segev DL
    Transplantation; 2019 Jun; 103(6):1216-1223. PubMed ID: 30247449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selected Mildly Obese Donors Can Be Used Safely in Simultaneous Pancreas and Kidney Transplantation.
    Alhamad T; Malone AF; Lentine KL; Brennan DC; Wellen J; Chang SH; Chakkera HA
    Transplantation; 2017 Jun; 101(6):1159-1166. PubMed ID: 27428713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding antihypertensive medication use after living kidney donation through linked national registry and pharmacy claims data.
    Lentine KL; Schnitzler MA; Garg AX; Xiao H; Axelrod D; Tuttle-Newhall JE; Brennan DC; Segev DL
    Am J Nephrol; 2014; 40(2):174-83. PubMed ID: 25196154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Center Variation and Risk Factors for Failure to Complete 6 Month Postdonation Follow-up Among Obese Living Kidney Donors.
    Reed RD; MacLennan PA; Shelton BA; Mustian MN; Blackburn J; Smith SC; Terry KB; Grant R; Sawinski D; Locke JE
    Transplantation; 2019 Jul; 103(7):1450-1456. PubMed ID: 31241556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure.
    Reddy KS; Stablein D; Taranto S; Stratta RJ; Johnston TD; Waid TH; McKeown JW; Lucas BA; Ranjan D
    Am J Kidney Dis; 2003 Feb; 41(2):464-70. PubMed ID: 12552511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emotional and Financial Experiences of Kidney Donors over the Past 50 Years: The RELIVE Study.
    Jacobs CL; Gross CR; Messersmith EE; Hong BA; Gillespie BW; Hill-Callahan P; Taler SJ; Jowsey SG; Beebe TJ; Matas AJ; Odim J; Ibrahim HN;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2221-31. PubMed ID: 26463883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription patterns of opioids and non-steroidal anti-inflammatory drugs in the first year after living kidney donation: An analysis of U.S. Registry and Pharmacy fill records.
    Vest LS; Sarabu N; Koraishy FM; Nguyen MT; Park M; Lam NN; Schnitzler MA; Axelrod D; Hsu CY; Garg AX; Segev DL; Massie AB; Hess GP; Kasiske BL; Lentine KL
    Clin Transplant; 2020 Aug; 34(8):e14000. PubMed ID: 32502285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pushing the envelope: living donor pancreas transplantation.
    Sutherland DE; Radosevich D; Gruessner R; Gruessner A; Kandaswamy R
    Curr Opin Organ Transplant; 2012 Feb; 17(1):106-15. PubMed ID: 22240639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and long-term mortality risk among living kidney donors.
    Locke JE; Reed RD; Massie AB; MacLennan PA; Sawinski D; Kumar V; Snyder JJ; Carter AJ; Shelton BA; Mustian MN; Lewis CE; Segev DL
    Surgery; 2019 Aug; 166(2):205-208. PubMed ID: 31072668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of living kidney donors over the past 28 years in a single center in Taiwan.
    Tsai SF; Shu KH; Ho HC; Wu MJ; Cheng CH; Lian JD; Wen MC; Su CK; Yu TM; Chuang YW; Huang ST; Chen CH
    Transplant Proc; 2012 Jan; 44(1):39-42. PubMed ID: 22310573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
    Gruessner AC; Sutherland DE
    Clin Transpl; 2008; ():45-56. PubMed ID: 19708445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying prognostic impact of prescription opioid use before kidney transplantation through linked registry and pharmaceutical claims data.
    Lentine KL; Yuan H; Tuttle-Newhall JE; Xiao H; Chawa V; Axelrod D; Brennan DC; Dharnidharka VR; Beuer C; Schnitzler MA
    Transplantation; 2015 Jan; 99(1):187-96. PubMed ID: 25531895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Assessment of Patients With Type 1 Diabetes Median 10 Years After Successful Simultaneous Pancreas and Kidney Transplantation Compared With Living Donor Kidney Transplantation.
    Lindahl JP; Massey RJ; Hartmann A; Aakhus S; Endresen K; Günther A; Midtvedt K; Holdaas H; Leivestad T; Horneland R; Øyen O; Jenssen T
    Transplantation; 2017 Jun; 101(6):1261-1267. PubMed ID: 27467687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer diagnoses after living kidney donation: linking U.S. Registry data and administrative claims.
    Lentine KL; Vijayan A; Xiao H; Schnitzler MA; Davis CL; Garg AX; Axelrod D; Abbott KC; Brennan DC
    Transplantation; 2012 Jul; 94(2):139-44. PubMed ID: 22825543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.